The role of glucuronidation in 7-ethyl-10-hydroxycamptothecin resistance in vitro

被引:47
作者
Takahashi, T
Fujiwara, Y
Yamakido, M
Katoh, O
Watanabe, H
Mackenzie, PI
机构
[1] Hiroshima Univ, Sch Med, Dept Internal Med 2, Minami Ku, Hiroshima 734, Japan
[2] Hiroshima Univ, Sch Med, Dept Integrated Med, Minami Ku, Hiroshima 734, Japan
[3] Hiroshima Univ, Res Inst Radiat Biol & Med, Dept Environm & Mutat, Minami Ku, Hiroshima 734, Japan
[4] Flinders Univ S Australia, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 1997年 / 88卷 / 12期
关键词
UDP-glucuronosyltransferase; drug resistance; CPT-11; SN-38; lung cancer;
D O I
10.1111/j.1349-7006.1997.tb00351.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although glucuronidation catalyzed by uridine 5'-diphosphoglucuronosyltransferase (UGT) is a major pathway of drug inactivation in humans, glucuronidation in malignant cells has received little attention as a cause of anti-cancer drug resistance. In this study, we tried to elucidate the role of SN-38 glucuronidation in the CPT-ll-resistant human lung cancer cell line PC-7/CPT, PC-7/CPT cells possessed an increased activity to glucuronidate SN-38 compared to the parent cells, PC-7, Furthermore, sensitivity of PC-7/CPT cells to SN-38 was improved by inhibiting UGT activity, Western and northern blot analyses demonstrated that this increased activity was due to increased levels of UGT protein and mRNA, These results not only imply that upregulation of UGT activity in PC-7/CPT cells may contribute in part to SN-38 resistance, but also illustrate the importance of drug metabolism within malignant cells themselves, as a cause of drug resistance.
引用
收藏
页码:1211 / 1217
页数:7
相关论文
共 32 条
[11]  
Haaz M. C., 1997, Proceedings of the American Association for Cancer Research Annual Meeting, V38, P17
[12]  
IYER L, 1997, P AN M AM SOC CLIN, V16, pA201
[13]   Genetic diseases of bilirubin metabolism: The inherited unconjugated hyperbilirubinemias [J].
Jansen, PLM .
JOURNAL OF HEPATOLOGY, 1996, 25 (03) :398-404
[14]  
KANZAWA F, 1990, CANCER RES, V50, P5919
[15]  
KANZAWA F, 1995, CANCER RES, V55, P2806
[16]  
KAWATO Y, 1991, CANCER RES, V51, P4187
[17]   DETECTION OF TOPOISOMERASE-I GENE POINT MUTATION IN CPT-11 RESISTANT LUNG-CANCER CELL-LINE [J].
KUBOTA, N ;
KANZAWA, F ;
NISHIO, K ;
TAKEDA, Y ;
OHMORI, T ;
FUJIWARA, Y ;
TERASHIMA, Y ;
SAIJO, N .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1992, 188 (02) :571-577
[18]  
Lavelle F, 1996, SEMIN ONCOL, V23, P11
[19]  
Lokiec F, 1996, CLIN CANCER RES, V2, P1943
[20]  
MACKENZIE PI, 1984, J BIOL CHEM, V259, P2153